About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,718 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,718 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3641-3660 of 13,718 trials

CompletedExtension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary FibrosisThe aim of this extension trial is to assess the long-term safety of BIBF 1120 treatment in patients with Idiopathic Pulmonary Fibrosis who have completed one year treatment and…NCT01619085·Jasper, Alabama and 172 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

CompletedRamucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)This phase II Lung-MAP non-Match treatment trial studies how well ramucirumab and pembrolizumab work versus standard of care in treating patients with non-small cell lung cancer…NCT03971474·Mobile, Alabama and 888 others

RecruitingA Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentThis study will collect information from patients with Alagille syndrome (ALGS) as they use odevixibat (Bylvay) in their daily lives.NCT06850038·Los Angeles, California and 9 others

Active not recruitingSafety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With MyelofibrosisMyelofibrosis (MF) is a bone marrow illness that affects blood-forming tissues in the body.NCT04454658·Sacramento, California and 42 others

RecruitingA Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Himalayas-1 is a randomized, open-label, global, multicenter phase 3 study evaluating whether the combination of rinzimetostat with darolutamide is more effective compared to…NCT07723248·Coral Springs, Florida and 11 others

TerminatedSciatica Epidural Radiculopathy Experimental New Interventional TherapY Clonidine MicropelletThis study will evaluate the safety and effectiveness of a new pain medication in development, clonidine micropellet.NCT05614648·Tucson, Arizona and 29 others

CompletedSafety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPSThe study will evaluate the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC) in HIV-infected subjects 18 years of age or older who…NCT00963235·San Francisco, California and 14 others

CompletedA Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid ArthritisThis study was designed to evaluate the safety of administering rituximab at a more rapid infusion rate in patients with moderate to severe rheumatoid arthritis who have had an…NCT01382940·Birmingham, Alabama and 85 others

TerminatedSafety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced CancerIT141 is a novel nanoparticle formulation of SN-38, the active metabolite of irinotecan, and is intended to deliver more drug to the tumor with reduced toxicity on normal tissues.NCT03096340·Dallas, Texas and 1 other

CompletedBelatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)The purpose of this study is to learn if Belatacept can provide protection from organ rejection following kidney transplantation while avoiding some of the toxic effects of…NCT00256750·Birmingham, Alabama and 104 others

Active not recruitingNivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III MeningiomaThis phase I/II trial studies the side effects and best dose of nivolumab when given together with multi-fraction stereotactic radiosurgery and to see how well they work with or…NCT03604978·Phoenix, Arizona and 28 others

Active not recruitingBosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid LeukemiaThis is a Phase 1-2, multicenter, international, single-arm, open-label study designed to identify a recommended dose of bosutinib administered orally once daily in pediatric…NCT04258943·Birmingham, Alabama and 58 others

Active not recruitingTrastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)The study will evaluate the efficacy and safety of trastuzumab deruxtecan (also known as T-DXd, DS-8201a), either alone or in combination with pertuzumab, in treating patients…NCT04784715·Tucson, Arizona and 282 others

Enrolling by invitationAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0There is a growing focus on short- and long-term kidney health in neonates, including those with acute kidney injury (AKI).NCT06823115·Birmingham, Alabama and 86 others

CompletedDiuretic Comparison ProjectThe Diuretic Comparison Project aimed to evaluate whether chlorthalidone, as compared with hydrochlorothiazide, would reduce the risk of major nonfatal cardiovascular disease…NCT02185417·Birmingham, Alabama and 69 others

CompletedSpeech Hero Home Therapy for AphasiaThe investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of…NCT04471935·Richardson, Texas

CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresThis study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with…NCT01261325·Phoenix, Arizona and 206 others

CompletedA Long-term Safety Study of Infliximab (Remicade)This is a study evaluating the long-term safety of infliximab (Remicade)NCT00261976·Birmingham, Alabama and 204 others

CompletedMechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based TherapyAsthma is a growing problem, especially in children. It causes frequent wheezing, shortness of breath, chest tightness, and cough.NCT02502890·Aurora, Colorado and 8 others

CompletedTRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureTRANSFORM-HF is a large-scale, pragmatic, randomized, unblinded clinical effectiveness study comparing torsemide versus furosemide as treatment for heart failure.NCT03296813·Alexander City, Alabama and 59 others

PreviousPage 183 of 686Next

Heart Diseasein Dallas